MFine, Datar Genetics launch cancer screening prog on mobile
14 February 2022 | News
Between 30-50% of all cancer cases are preventable and prevention offers the most cost-effective long-term strategy for the control of cancer
Image credit: Shutterstock
MFine in association with Datar Cancer Genetics has announced the launch of a Comprehensive Cancer Screening Programme on the MFine app.
Datar Cancer Screening Tests can now be booked on the MFine app, helping patients detect cancer at an early stage. MFine users will be able to book the Datar EasyCheck360 (multiple cancers), EasyCheck FemmeSafe (women’s cancers) and EasyCheck Prostate cancer screening tests through the app. The partnership will also allow users to book the Datar EasyCheck Diabetes test.
EasyCheck is a radiation-free, globally recognised simple blood test for early cancer detection. EasyCheck360 is non-invasive, radiation-free and can be availed from the comfort of office or home through MFine App. It is intended to be performed annually as a screening test, in individuals without any symptoms suggestive of cancer and aged 30+ years can detect more than 30 cancers.
